Literature DB >> 27858355

Characterization of Cancer Stem Cells.

Stefania Orecchioni1, Francesco Bertolini2.   

Abstract

There is biological and clinical evidence that mammalian tumors are highly heterogeneous at single-cell level, and that only a minority of the cancer cells have limitless replicative potential in vitro and in vivo. Here we review the different strategies currently used for the functional isolation of cancer cells with in vivo cancer initiation potential and self-renewal. These tools are currently used to better define their molecular, phenotypic, and drug-resistance characteristics in preclinical and clinical studies.

Entities:  

Keywords:  Aldehyde dehydrogenase; Cancer stem cells; Cancer-initiating cells; FACS; Methods; Side population; Tumorigenicity; Tumorspheres

Mesh:

Substances:

Year:  2016        PMID: 27858355     DOI: 10.1007/978-1-4939-3999-2_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells.

Authors:  Jun Hu; Jian Li; Xin Yue; Jia-Cang Wang; Jun-Feng Wang; Jian-Zhong Liu; Da-Lu Kong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-04-11

2.  Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.

Authors:  Tomoka Takao; Hirotaka Masuda; Takashi Kajitani; Fumie Miki; Kaoru Miyazaki; Yushi Yoshimasa; Satomi Katakura; Shoko Tomisato; Sayaka Uchida; Hiroshi Uchida; Mamoru Tanaka; Tetsuo Maruyama
Journal:  Stem Cell Res Ther       Date:  2022-06-03       Impact factor: 8.079

3.  Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2.

Authors:  Manuel Pedro Jimenez-García; Antonio Lucena-Cacace; Daniel Otero-Albiol; Amancio Carnero
Journal:  Cell Death Dis       Date:  2021-05-20       Impact factor: 8.469

Review 4.  Ovarian cancer stem cells: still an elusive entity?

Authors:  Michela Lupia; Ugo Cavallaro
Journal:  Mol Cancer       Date:  2017-03-20       Impact factor: 27.401

5.  Biology and Bias in Cell Type-Specific RNAseq of Nucleus Accumbens Medium Spiny Neurons.

Authors:  Hope Kronman; Felix Richter; Benoit Labonté; Ramesh Chandra; Shan Zhao; Gabriel Hoffman; Mary Kay Lobo; Eric E Schadt; Eric J Nestler
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

6.  Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.

Authors:  Wei-Ching Chen; Minh D To; Peter M K Westcott; Reyno Delrosario; Il-Jin Kim; Mark Philips; Quan Tran; Saumya R Bollam; Hani Goodarzi; Nora Bayani; Olga Mirzoeva; Allan Balmain
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

7.  TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis.

Authors:  Dae Kyoung Kim; Yu Na Kim; Ye Eun Kim; Seo Yul Lee; Min Joo Shin; Eun Kyoung Do; Kyung-Un Choi; Seung-Chul Kim; Ki-Hyung Kim; Dong-Soo Suh; Parkyong Song; Jae Ho Kim
Journal:  Mol Cells       Date:  2021-07-31       Impact factor: 5.034

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.